Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Rigid Endoscopes Market size was valued at USD 8.02 billion in 2024 and is likely to cross USD 19.09 billion by 2037, registering more than 6.9% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of rigid endoscopes is estimated at USD 8.93 billion.
The market is growing mainly due to the increasing preference for minimally invasive surgical (MIS) procedures to minimize patient trauma. Every year, over 13 million laparoscopic procedures are performed worldwide. These figures are expected to rise by 1% over the next five years.
The growing demand for early diagnosis through minimally invasive procedures drives the use of rigid endoscopes in the healthcare industry, which includes shorter hospital stays, less pain, and fewer complications among patients. This, in turn, improves patient outcomes and treatment efficiency, thereby aiding market growth.
Rigid Endoscopes Sector: Growth Drivers and Challenges
Growth Drivers
- Increasing Prevalence of Chronic Illnesses – Growing chronic illnesses such as cancer and gastrointestinal conditions that necessitate accurate diagnosis and treatment are projected to increase the adoption of rigid endoscopes thereby, driving the rigid endoscopes market growth. The fifth most common cancer in the world is stomach cancer. In 2020, there were over a million new cases of stomach cancer.
- Rising Cases of Obesity – Obesity is associated with a variety of gastrointestinal problems, including gastroesophageal reflux disease, esophageal adenocarcinoma, colorectal polyps, and erosive esophagitis. Furthermore, indigestion caused by lactose intolerance, incorrect diagnosis, and ignorance is pushing patients to test themselves. This has increased the demand for rigid endoscopes, in turn impeding the rigid endoscopes market growth.
- High Expenditure on the Medical Devices Sector – High investments have been made in the medical device industry as a result of the rising global burden brought on by the rise in the prevalence of chronic and acute diseases. These are used to develop smart diagnostic and monitoring medical devices, like rigid endoscopes for therapeutic procedures. In 2022, large medical device companies increased their R&D expenditures from more than USD 1 billion to USD 24 billion.
Challenges
- Limited availability of Skilled Professionals - Healthcare resources in developing and underdeveloped economies are insufficient, resulting in inequitable access to healthcare resources. As a result, there aren't enough qualified healthcare workers.
- High Cost of Advanced Devices
- Rising Excise Tax on Manufacturers
Rigid Endoscopes Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
6.9% |
|
Base Year Market Size (2024) |
USD 8.02 billion |
|
Forecast Year Market Size (2037) |
USD 19.09 billion |
|
Regional Scope |
|
Rigid Endoscopes Segmentation
Product (Laparoscopes, Arthroscopes, Ureteroscopes, Cystoscopes, Gynecology Endoscopes, Neuroendoscopes, Bronchoscopes, Hysteroscopes)
The product segment is estimated to hold around 29% share of the global rigid endoscopes market by the end of 2037 as a result of the increasing rate of surgeries conducted such as hernias, appendicitis, hysterectomy, endometriosis, cholecystitis, and others. Almost 10% of the population in the United States develops some type of hernia during life and more than 1 million abdominal hernia laparoscopic repairs are performed each year.
End-Use (Hospitals, Outpatient Facilities)
The hospitals sub-segment is expected to gain a prominent share of the rigid endoscopes market by 2037 because hospitals employ skilled surgeons, and most patients choose to have endoscope-related surgeries there. Endoscopic surgery patients make up a sizable portion of hospital patients, which is anticipated to support the segment growth.
Our in-depth analysis of the global market includes the following segments:
|
Product |
|
|
End-Use |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportRigid Endoscopes Industry - Regional Synopsis
North American Market Forecast
North America industry is predicted to dominate majority revenue share of 38% by 2037, as a result of the increasing awareness about endoscopic surgeries for the diagnosis and treatment of various acute and chronic diseases. In the coming years, the region is also expected to present lucrative growth opportunities for market expansion due to rising cancer tumor prevalence, strong healthcare infrastructure, and the availability of prominent key players. According to the American Cancer Society, more than 1.8 million new cases of cancer were identified in the U.S. in 2021.
APAC Market Analysis
The rigid endoscopes market in Asia Pacific will register a revenue share of more than 28% by the end of 2037. The market is expanding as a result of the region's growing preference for elective endoscopic surgeries, increased healthcare spending, and a rapidly growing geriatric population. According to the World Health Organization, the proportion of people aged 60 years and above in the South East Asia region was 9.5% in 2017, and it is expected to rise to 13.2% and 19.8% by 2030 and 2050, respectively.
Companies dominating the Rigid Endoscopes Landscape
- Pristine Surgical
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Olympus Corporation
- Ethicon U.S., LLC
- Boston Scientific Corporation
- Karl Storz GmbH & Co. KG
- Stryker
- PENTAX Medical
- Richard Wolf
- Medtronic
In the News
Pristine Surgical has finally been granted 510(k) clearance for its Summit 4K single-use surgical arthroscope from the US FDA. This latest version is estimated to improve the safety, consistency, and efficiency of arthroscopic procedures.
Olympus Corporation has announced its decisive decision to acquire Quest Photonic Devices B.V. This acquisition is projected to strengthen the company’s surgical endoscopy capabilities.
Author Credits: Radhika Pawar
- Report ID: 5082
- Published Date: Dec 20, 2024
- Report Format: PDF, PPT
